Characterization of CYP2A4 and CYP2A5 responsible for coxidation of nicotine in mouse liver microsomes

被引：0
|
作者：
Miyazaki, M [1 ]
Yamazaki, H [1 ]
Kimura, M [1 ]
Kamataki, T [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Sapporo, Hokkaido 0600812, Japan
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
108
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [21] CRY1/2 regulate rhythmic CYP2A5 in mouse liver through repression of E4BP4
    Lin, Luomin
    Huang, Yuwei
    Wang, Jinyi
    Guo, Xiaocao
    Yu, Fangjun
    He, Di
    Wu, Chuanbin
    Guo, Lianxia
    Wu, Baojian
    BIOCHEMICAL PHARMACOLOGY, 2023, 217
  • [22] Plasmodium berghei (ANKA):: Infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver
    De-Oliveira, Ana C. A. X.
    Da-Matta, Anndressa C.
    Pauragartten, Francisco J. R.
    EXPERIMENTAL PARASITOLOGY, 2006, 113 (04) : 256 - 261
  • [23] Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice
    Bagdas, Deniz
    Muldoon, Pretal P.
    Zhu, Andy Z. X.
    Tyndale, Rachel F.
    Damaj, M. Imad
    NEUROPHARMACOLOGY, 2014, 85 : 67 - 72
  • [24] Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes
    Anneli Kojo
    Pirkko Viitala
    Markku Pasanen
    Olavi Pelkonen
    Hannu Raunio
    Risto Juvonen
    Archives of Toxicology, 1998, 72 : 336 - 341
  • [25] Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes
    Kojo, A
    Viitala, P
    Pasanen, M
    Pelkonen, O
    Raunio, H
    Juvonen, R
    ARCHIVES OF TOXICOLOGY, 1998, 72 (06) : 336 - 341
  • [26] Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms
    Deng, Xiao
    Pu, Qianghong
    Wang, Erhao
    Yu, Chao
    ONCOLOGY LETTERS, 2016, 12 (06) : 5309 - 5314
  • [27] Ethanol Induction of CYP2A5: Permissive Role for CYP2E1
    Lu, Yongke
    Zhuge, Jian
    Wu, Defeng
    Cederbaum, Arthur I.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (02) : 330 - 336
  • [28] PPARα interplays with CYP2A5 to protect against fatty liver disease
    Chen, Xue
    Lu, Yongke
    HEPATOLOGY, 2017, 66 : 1067A - 1067A
  • [29] Respective Roles of CYP2A5 and CYP2F2 in the Bioactivation of 3-Methylindole in Mouse Olfactory Mucosa and Lung: Studies Using Cyp2a5-Null and Cyp2f2-Null Mouse Models
    Zhou, Xin
    D'Agostino, Jaime
    Li, Lei
    Moore, Chad D.
    Yost, Garold S.
    Ding, Xinxin
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 642 - 647
  • [30] CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes
    Ramírez, J
    Innocenti, F
    Schuetz, EG
    Flockhart, DA
    Relling, MV
    Santucci, R
    Ratain, MJ
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (09) : 930 - 936
12345